Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Tables and Figures from Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor–Resistant, EGFR-Mutated Non–Small Cell Lung Cancer
  1. Home
  2. Publications
  3. Supplementary Tables and Figures from Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor–Resistant, EGFR-Mutated Non–Small Cell Lung Cancer

Supplementary Tables and Figures from Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor–Resistant, EGFR-Mutated Non–Small Cell Lung Cancer

Authors:
  • PJPasi A. Jänne
    Pasi A. Jänne
  • CBChristina Baik
    Christina Baik
  • Wu-Chou Su
    Wu-Chou Su
  • MJMelissa L. Johnson
    Melissa L. Johnson
  • HHHidetoshi Hayashi
    Hidetoshi Hayashi
  • MNMakoto Nishio
    Makoto Nishio
  • DKDong-Wan Kim
    Dong-Wan Kim
  • MKMarianna Koczywas
    Marianna Koczywas
  • KGKathryn A. Gold
    Kathryn A. Gold
  • CSConor E. Steuer
    Conor E. Steuer
  • HMHaruyasu Murakami
    Haruyasu Murakami
  • JYJames Chih-Hsin Yang
    James Chih-Hsin Yang

Open Access
Publisher website
Google Scholar
  • 3 April 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2159-8290.22540561.v1
Abstract
No abstract available
Keywords
  • EGFR INHIBITORS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.